Clinical Trial Update: Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial to evaluate colchicine for uremic cardiomyopathy in patients with chronic kidney disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Uremic Cardiomyopathy

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Chronic Kidney Diseases | Phase 2 | Status: RECRUITING